10-Q Filing

IOVANCE BIOTHERAPEUTICS, INC. CIK: 1425205 Q3 2019

Filing Information

Form Type	10-Q
Accession Number	`0001104659-19-059564`
Period End Date	20190930
Filing Date	20191104
Fiscal Year	2019
Fiscal Period	Q3
XBRL Instance	iova-20190930x10q4611ce_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 62 Income Statement 32 Cash Flow Statement 52 Stockholders Equity 41 Comprehensive Income 12

Balance Sheet 62 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$80.74M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$82.15M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$38.89M	USD	Point-in-time
Short-term investments	`AvailableForSaleSecuritiesCurrent`	$386.37M	USD	Point-in-time
Short-term investments	`AvailableForSaleSecuritiesCurrent`	$322.99M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.43M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$6.64M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$367.31M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$475.16M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$13.74M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$10.40M	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.86M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.68M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Restricted cash	`RestrictedCash`	$5.45M	USD	Point-in-time
Long-term assets	`OtherAssetsNoncurrent`	$2.98M	USD	Point-in-time
Long-term assets	`OtherAssetsNoncurrent`	$3.40M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	126.19M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	123.42M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	123.42M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	126.19M	shares	Point-in-time
Total Assets	`Assets`	$395.75M	USD	Point-in-time
Total Assets	`Assets`	$480.82M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.74M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$9.92M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$16.32M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$11.66M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$4.90M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$8.37M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$34.61M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$14.40M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$6.02M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$5.80M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$230.00K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$53.00K	USD	Point-in-time
Total Non-Current Liabilities	`LiabilitiesNoncurrent`	$230.00K	USD	Point-in-time
Total Non-Current Liabilities	`LiabilitiesNoncurrent`	$6.07M	USD	Point-in-time
Total Liabilities	`Liabilities`	$14.63M	USD	Point-in-time
Total Liabilities	`Liabilities`	$40.68M	USD	Point-in-time
Commitments and contingencies (Notes 8 and 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Notes 8 and 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.000041666 par value; 300,000,000 and 150,000,000 shares authorized, 126,192,990 and 123,415,576 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively	`CommonStockValue`	$5.00K	USD	Point-in-time
Common stock, $0.000041666 par value; 300,000,000 and 150,000,000 shares authorized, 126,192,990 and 123,415,576 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively	`CommonStockValue`	$5.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$239.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$-42.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$861.86M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$838.98M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-372.76M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-507.04M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$466.19M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$355.06M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$397.42M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$145.48M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$254.16M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$270.57M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$395.75M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$480.82M	USD	Point-in-time

Income Statement 32 line items

Line Item	Tag	Value	Unit	Period
Research and development expenses	`ResearchAndDevelopmentExpense`	$27.95M	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpense`	$72.41M	USD	3 Qtrs
Research and development expenses	`ResearchAndDevelopmentExpense`	$41.58M	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpense`	$111.78M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$29.98M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$10.03M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$20.91M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$7.11M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$35.06M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$141.76M	USD	3 Qtrs
Total costs and expenses	`OperatingExpenses`	$93.31M	USD	3 Qtrs
Total costs and expenses	`OperatingExpenses`	$51.61M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-141.76M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-35.06M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-93.31M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-51.61M	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$1.23M	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$2.31M	USD	3 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$7.77M	USD	3 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$2.12M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-133.99M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-33.83M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-49.49M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-91.00M	USD	3 Qtrs
Net Loss Per Common Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-1.08	USD	3 Qtrs
Net Loss Per Common Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.40	USD	1 Quarter
Net Loss Per Common Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-1.01	USD	3 Qtrs
Net Loss Per Common Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.36	USD	1 Quarter
Weighted Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	124,035.00	shares	1 Quarter
Weighted Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	123,674.00	shares	3 Qtrs
Weighted Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	95,077.00	shares	1 Quarter
Weighted Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89,927.00	shares	3 Qtrs

Cash Flow Statement 52 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-133.99M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-33.83M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-49.49M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-91.00M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$704.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$875.00K	USD	3 Qtrs
Noncash lease expense	`NonCashLeaseExpense`	$4.96M	USD	3 Qtrs
Loss on disposal of assets	`GainLossOnDispositionOfAssets`	$-9.00K	USD	3 Qtrs
Gain on settlement of dispute	`GainLossRelatedToLitigationSettlement`	$336.00K	USD	3 Qtrs
Accretion of discounts on investments	`AmortizationOfDebtDiscountPremium`	$-3.04M	USD	3 Qtrs
Accretion of discounts on investments	`AmortizationOfDebtDiscountPremium`	$-388.00K	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$18.87M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$14.84M	USD	3 Qtrs
Prepaid expenses, other assets, and long-term assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-785.00K	USD	3 Qtrs
Prepaid expenses, other assets, and long-term assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$644.00K	USD	3 Qtrs
Operating lease liabilities (Right-of-use assets)	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-4.31M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$4.78M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$6.62M	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$2.00M	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$4.49M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-69.70M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-105.07M	USD	3 Qtrs
Maturities of short-term investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$420.58M	USD	3 Qtrs
Purchase of short-term investments	`PaymentsToAcquireAvailableForSaleSecurities`	$353.88M	USD	3 Qtrs
Purchase of short-term investments	`PaymentsToAcquireAvailableForSaleSecurities`	$178.99M	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$903.00K	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.49M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-179.90M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$63.21M	USD	3 Qtrs
Tax payments related to shares withheld for vested restricted stock awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$193.00K	USD	3 Qtrs
Tax payments related to shares withheld for vested restricted stock awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$181.00K	USD	3 Qtrs
Proceeds from the issuance of common stock upon exercise of warrants	`ProceedsFromWarrantExercises`	$14.68M	USD	3 Qtrs
Proceeds from the issuance of common stock upon exercise of options	`ProceedsFromStockOptionsExercised`	$8.37M	USD	3 Qtrs
Proceeds from the issuance of common stock upon exercise of options	`ProceedsFromStockOptionsExercised`	$4.24M	USD	3 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$162.09M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$184.96M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.04M	USD	3 Qtrs
Net decrease in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-37.81M	USD	3 Qtrs
Net decrease in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-64.64M	USD	3 Qtrs
Cash, Cash Equivalents, and Restricted Cash Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$145.37M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$82.15M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$80.74M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$44.34M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$145.37M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$82.15M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$80.74M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$44.34M	USD	Point-in-time
Unrealized gain (loss) on short-term investments	`UnrealizedGainLossOnShorttermInvestments`	$-120.00K	USD	3 Qtrs
Unrealized gain (loss) on short-term investments	`UnrealizedGainLossOnShorttermInvestments`	$281.00K	USD	3 Qtrs
Acquisitions of property and equipment included in accounts payable	`LeaseholdImprovementsPaidByLandlord`	$557.00K	USD	3 Qtrs
Conversion of convertible preferred stock to common stock	`ConversionOfStockAmountConverted1`	$1.00K	USD	3 Qtrs
Conversion of convertible preferred stock to common stock	`ConversionOfStockAmountConverted1`	$2.00K	USD	3 Qtrs

Stockholders Equity 41 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$466.19M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$355.06M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$397.42M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$145.48M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$254.16M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$270.57M	USD	Point-in-time
Adoption of ASU 2018-07	`CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption`	$300.00K	USD	Point-in-time
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$14.84M	USD	3 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$6.60M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$5.52M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$18.87M	USD	3 Qtrs
Tax payments related to shares withheld for vested restricted stock awards	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$-99.00K	USD	1 Quarter
Tax payments related to shares withheld for vested restricted stock awards	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$-193.00K	USD	3 Qtrs
Tax payments related to shares withheld for vested restricted stock awards	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$-181.00K	USD	3 Qtrs
Tax payments related to shares withheld for vested restricted stock awards	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$-59.00K	USD	1 Quarter
Common stock issued upon exercise of warrants	`CommonStockIssuedUponExerciseOfWarrantsAmount`	$14.68M	USD	3 Qtrs
Common stock issued upon exercise of warrants	`CommonStockIssuedUponExerciseOfWarrantsAmount`	$10.54M	USD	1 Quarter
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$762.00K	USD	1 Quarter
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.54M	USD	1 Quarter
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$4.24M	USD	3 Qtrs
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$8.37M	USD	3 Qtrs
Unrealized gain / (loss) on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-117.00K	USD	1 Quarter
Unrealized gain / (loss) on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-120.00K	USD	3 Qtrs
Unrealized gain / (loss) on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$281.00K	USD	3 Qtrs
Unrealized gain / (loss) on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-133.00K	USD	1 Quarter
Common stock sold in public offering, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$162.09M	USD	3 Qtrs
Common stock sold in public offering, net of offering costs (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	50,000.00	shares	Point-in-time
Common stock sold in public offering, net of offering costs (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	17,500.00	shares	1 Quarter
Common stock sold in public offering, net of offering costs (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	25.30M	shares	Point-in-time
Conversion of convertible preferred stock into common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$1.00K	USD	1 Quarter
Cancellation of common shares from settlement of dispute	`StockCancelledDuringPeriodSharesOfCommonStock`	$-336.00K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-133.99M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-33.83M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-49.49M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-91.00M	USD	3 Qtrs
Ending Balance	`StockholdersEquity`	$466.19M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$355.06M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$397.42M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$145.48M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$254.16M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$270.57M	USD	Point-in-time

Comprehensive Income 12 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLoss`	$-133.99M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-33.83M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-49.49M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-91.00M	USD	3 Qtrs
Unrealized gain / (loss) on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-117.00K	USD	1 Quarter
Unrealized gain / (loss) on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-120.00K	USD	3 Qtrs
Unrealized gain / (loss) on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$281.00K	USD	3 Qtrs
Unrealized gain / (loss) on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-133.00K	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-33.95M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-49.62M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-91.12M	USD	3 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-133.71M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.